ANDA Labeling Guidance Gives "Short Shrift" To Product Innovation - J&J
This article was originally published in The Tan Sheet
Executive Summary
FDA's draft guidance proposing ANDAs be allowed to reference discontinued labeling would unfairly favor generic firms and lessen branded companies' incentives to explore product innovation, Johnson & Johnson maintains in comments to the agency.